Autopsy report · NCT02357225
A Pilot Study of Pyridostigmine in Pompe Disease
Cause of deathFutility
“The drug was ineffective in improving function in Pompe's disease”
Life of this trial
- Registered 7 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Early Phase 1
- Sponsor
- University of Florida
- Sponsor type
- University, hospital or other
- Conditions
- Pompe Disease
- Interventions
- Pyridostigmine Bromide
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.